Insider / LABCORP HOLDINGS INC.
Vaughn Bryan T
EVP, Diagnostics at LABCORP HOLDINGS INC.
- Company
- LABCORP HOLDINGS INC.
- Ticker
- LH
- First filing on record
- February 10, 2026
- Latest trade on record
- September 1, 2026
- SEC filings
- EDGAR ↗
Vaughn Bryan T, EVP, Diagnostics at LABCORP HOLDINGS INC., has disclosed 18 transactions in LH since February 10, 2026: 0 purchases (0 open-market buys) and 6 sales, worth about $275K at the reported prices. The latest was filed September 3, 2026, 2 days after the trade; 3 filings were late against the 2-business-day Form 4 deadline.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Vaughn Bryan T made no purchases and 6 sales worth $275K, plus 12 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Vaughn Bryan T has traded 1 stock on record; the largest by dollars is LH.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
1 of 6 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 8 | 2,016 | — |
| F | Shares withheld for tax | 5 | 759 | $208K |
| A | Grant or award | 4 | 6,014 | — |
| S | Open-market sale | 1 | 234 | $67K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 18 | 0 | 6 · $275K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| LH | Other A | September 1, 2026 | September 3, 2026 | 2d | 1,500 | — | — | derivative | Form 4 ↗ | |
| LH | Option / conversion M | July 1, 2026 | July 6, 2026 | 5d | 327 | — | — | late10b5-1 planderivative | Form 4 ↗ | |
| LH | Sell S | July 2, 2026 | July 6, 2026 | 4d | 234 | $286 | $67K | 10b5-1 plan | Form 4 ↗ | |
| LH | Sell F | July 1, 2026 | July 6, 2026 | 5d | 93 | $284 | $26K | late10b5-1 plan | Form 4 ↗ | |
| LH | Option / conversion M | July 1, 2026 | July 6, 2026 | 5d | 327 | — | — | late10b5-1 plan | Form 4 ↗ | |
| LH | Sell F | March 26, 2026 | March 30, 2026 | 4d | 451 | $268 | $121K | Form 4 ↗ | ||
| LH | Other A | March 26, 2026 | March 30, 2026 | 4d | 1,584 | — | — | Form 4 ↗ | ||
| LH | Option / conversion M | February 11, 2026 | February 13, 2026 | 2d | 323 | — | — | derivative | Form 4 ↗ | |
| LH | Sell F | February 11, 2026 | February 13, 2026 | 2d | 93 | $290 | $27K | Form 4 ↗ | ||
| LH | Option / conversion M | February 11, 2026 | February 13, 2026 | 2d | 323 | — | — | Form 4 ↗ | ||
| LH | Other A | February 10, 2026 | February 12, 2026 | 2d | 730 | — | — | derivative | Form 4 ↗ | |
| LH | Other A | February 10, 2026 | February 12, 2026 | 2d | 2,200 | — | — | derivative | Form 4 ↗ | |
| LH | Option / conversion M | February 7, 2026 | February 10, 2026 | 3d | 178 | — | — | derivative | Form 4 ↗ | |
| LH | Option / conversion M | February 6, 2026 | February 10, 2026 | 4d | 180 | — | — | derivative | Form 4 ↗ | |
| LH | Sell F | February 9, 2026 | February 10, 2026 | 1d | 61 | $274 | $17K | Form 4 ↗ | ||
| LH | Option / conversion M | February 7, 2026 | February 10, 2026 | 3d | 178 | — | — | Form 4 ↗ | ||
| LH | Sell F | February 6, 2026 | February 10, 2026 | 4d | 61 | $277 | $17K | Form 4 ↗ | ||
| LH | Option / conversion M | February 6, 2026 | February 10, 2026 | 4d | 180 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| September 3, 2026 | Form 4 | 0000920148-26-000191 | 1 | published | EDGAR ↗ |
| July 6, 2026 | Form 4 | 0000920148-26-000151 | 4 | published | EDGAR ↗ |
| March 30, 2026 | Form 4 | 0000920148-26-000121 | 2 | published | EDGAR ↗ |
| February 13, 2026 | Form 4 | 0000920148-26-000089 | 3 | published | EDGAR ↗ |
| February 12, 2026 | Form 4 | 0000920148-26-000067 | 2 | published | EDGAR ↗ |
| February 10, 2026 | Form 4 | 0000920148-26-000027 | 6 | published | EDGAR ↗ |
Other insiders at LABCORP HOLDINGS INC.
- Wengel Kathryn E EVP, Chief TO and Risk Officer 24 rows
- Schechter Adam H Director 22 rows
- Wilkinson Peter J SVP, Chief Accounting Officer 22 rows
- Caveney Brian J EVP, Pres of ED, CMO & CSO 20 rows
- Bailey Megan D. EVP, Pres, Central Labs & Intl 19 rows
- Kyle Kathryn W EVP, Chief Legal Officer 18 rows
- Meltzer Jonathan C EVP, Operations 18 rows
- Oyegunwa Akinbolade EVP, CIO & CTO 17 rows
- Schroeder Mark S EVP, Pres Diagnostics & COO 16 rows
- Summy Amy B. EVP, Chief Marketing Officer 14 rows
Everyone on file, with contracts and lobbying under the company's name: LABCORP HOLDINGS INC..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 6 | 18 | February 10, 2026 | September 3, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.